Nasdaq · Healthcare
GE HealthCare Technologies Inc. (GEHC)
As-reported financials and recent SEC filings for GE HealthCare Technologies Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$20.63B
Net income
$2.08B
Net margin
10.1%
Diluted EPS
$4.55
ROE
20.1%
P/E (TTM)
15.6×
Market cap
$29.65B
Debt / equity
0.9×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $20.63B | $19.67B | $19.55B | $18.34B | $17.59B |
| Gross profit | — | — | — | — | — |
| Operating income | $2.76B | $2.63B | $2.44B | $2.52B | $2.79B |
| Net income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
| Diluted EPS | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-05-29
View on EDGAR →42026-05-26
View on EDGAR →42026-05-19
View on EDGAR →42026-05-19
View on EDGAR →SCHEDULE 13G/A2026-05-14
View on EDGAR →SCHEDULE 13G/A2026-05-14
View on EDGAR →42026-05-13
View on EDGAR →42026-05-11
View on EDGAR →Go deeper on GEHC
Search GE HealthCare Technologies Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.